Design Therapeutics Stock Price on October 23, 2024
| DSGN Stock | USD 5.57 0.09 1.64% |
If you're considering investing in Design Stock, it is important to understand the factors that can impact its price. As of today, the current price of Design Therapeutics stands at 5.57, as last reported on the 22nd of November, with the highest price reaching 5.73 and the lowest price hitting 5.43 during the day. Design Therapeutics appears to be moderately volatile, given 3 months investment horizon. Design Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0391, which denotes the company had a 0.0391% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Design Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Design Therapeutics' Mean Deviation of 4.28, downside deviation of 5.91, and Coefficient Of Variation of 1510.0 to check if our risk estimates are consistent with your expectations.
At this time, Design Therapeutics' Stock Based Compensation is very stable compared to the past year. As of the 22nd of November 2024, Sale Purchase Of Stock is likely to grow to about 307.3 K, while Total Stockholder Equity is likely to drop about 213.9 M. . At this time, Design Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 22nd of November 2024, Price To Book Ratio is likely to grow to 0.56, while Price To Sales Ratio is likely to drop about 2.5 M. Design Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Design |
Sharpe Ratio = 0.0391
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DSGN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.7 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Design Therapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Design Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.2291 | Enterprise Value Ebitda (0.84) | Price Sales 22.6 K | Shares Float 25.2 M | Wall Street Target Price 7 |
Related Headline
Transcode Therapeutics Headline on 23rd of October 2024
TransCode Therapeutics Announces Safety Review Committee App... by finance.yahoo.com
The clinical trial Safety Review Committee approved opening of Cohort 2 after review of safety data from the three patients comprising Cohort 1No significant safety or dose limiting toxicities have been reported in Cohort 1Patients are currently being evaluated for eligibility in Cohort 2TTX-MC138 is a therapeutic candidate based on microRNAmicroRNA technology was recognized with the 2024 Nobel Prize in Physiology and MedicineTransCode is the only company with an ongoing US clinical trial
Design Therapeutics Valuation on October 23, 2024
It is possible to determine the worth of Design Therapeutics on a given historical date. On October 23, 2024 Design was worth 5.6 at the beginning of the trading date compared to the closed value of 5.66. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Design Therapeutics stock. Still, in general, we apply an absolute valuation method to find Design Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Design Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Design Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 5.56 | 5.78 | 5.43 | 5.67 | 80,199 | |
10/23/2024 | 5.60 | 5.69 | 5.47 | 5.66 | 77,338 |
| 5.68 | 5.78 | 5.33 | 5.35 | 55,931 |
| Backtest Design Therapeutics | | | Design Therapeutics History | | | Design Therapeutics Valuation | Previous | Next |
Design Therapeutics Trading Date Momentum on October 23, 2024
| On October 24 2024 Design Therapeutics was traded for 5.35 at the closing time. The top price for the day was 5.78 and the lowest listed price was 5.33 . The trading volume for the day was 55.9 K. The trading history from October 24, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.48% . The overall trading delta against the current closing price is 9.01% . |
Design Therapeutics Fundamentals Correlations and Trends
By evaluating Design Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Design Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Design financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Design Therapeutics Stock history
Design Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Design is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Design Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Design Therapeutics stock prices may prove useful in developing a viable investing in Design Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 56 M | 46.6 M | |
| Net Loss | -57 M | -54.1 M |
Design Therapeutics Quarterly Net Working Capital |
|
Design Therapeutics Stock Technical Analysis
Design Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Design Therapeutics Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Design Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Design Therapeutics November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Design Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Design Therapeutics shares will generate the highest return on investment. By undertsting and applying Design Therapeutics stock market strength indicators, traders can identify Design Therapeutics entry and exit signals to maximize returns
Design Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Design Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Design Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Design to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0586 | |||
| Jensen Alpha | 0.3532 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.049 | |||
| Treynor Ratio | 1.47 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Design Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Design Therapeutics. If investors know Design will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Design Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.85) | Revenue Per Share 0.001 | Return On Assets (0.14) | Return On Equity (0.18) |
The market value of Design Therapeutics is measured differently than its book value, which is the value of Design that is recorded on the company's balance sheet. Investors also form their own opinion of Design Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Design Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Design Therapeutics' market value can be influenced by many factors that don't directly affect Design Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Design Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Design Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Design Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.